Literature DB >> 15332717

Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method.

C Tascini1, R Doria, A Leonildi, C Martinelli, F Menichetti.   

Abstract

The case of a patient with highly gentamicin-resistant Enterococcus faecalis endocarditis treated with an ampicillin + ceftriaxone combination is described. We have designed a method to evaluate synergism between the antibacterial activity of patient's serum taken during a given antibiotic regimen (ampicillin) to which another antibiotic (ceftriaxone) is added in vitro. In this patient the two-drug combination was able to stop the bacteremia and prevent the infection of the prosthetic valve.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15332717     DOI: 10.1179/joc.2004.16.4.400

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  5 in total

1.  Endocarditis caused by resistant enterococcus: an overview.

Authors:  Katherine Reyes; Marcus Zervos
Journal:  Curr Infect Dis Rep       Date:  2013-08       Impact factor: 3.725

2.  In vitro trials of some antimicrobial combinations against Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Zafar Ahmed; Shaukat Saeed Khan; Mahnaaz Khan
Journal:  Saudi J Biol Sci       Date:  2012-11-10       Impact factor: 4.219

3.  Ampicillin-Ceftriaxone vs Ampicillin-Gentamicin for Definitive Therapy of Enterococcus faecalis Infective Endocarditis: A Propensity Score-Matched, Retrospective Cohort Analysis.

Authors:  Niyati H Shah; Kathleen A Shutt; Yohei Doi
Journal:  Open Forum Infect Dis       Date:  2021-03-06       Impact factor: 3.835

Review 4.  Intrinsic and acquired resistance mechanisms in enterococcus.

Authors:  Brian L Hollenbeck; Louis B Rice
Journal:  Virulence       Date:  2012-08-15       Impact factor: 5.882

5.  In vitro Antimicrobial Activity of Ampicillin-Ceftriaxone and Ampicillin-Ertapenem Combinations Against Clinical Isolates of Enterococcus faecalis with High Levels of Aminoglycoside Resistance.

Authors:  Maria Bruna Pasticci; Antonella Mencacci; Amedeo Moretti; Nicola Palladino; Luigi Maria Lapalorcia; Francesco Bistoni; Franco Baldelli
Journal:  Open Microbiol J       Date:  2008-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.